NCT07089498

Brief Summary

The goal of this interventional study is the evaluation of a diet low in fodmaps on gastric emptying in celiac patients with functional disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

July 28, 2025

Completed
Last Updated

July 28, 2025

Status Verified

December 1, 2022

Enrollment Period

2.8 years

First QC Date

January 4, 2023

Last Update Submit

July 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluating gastric emptying time by a 13C-Octanoic Acid Breath Test, pre and post-diet (T1 and T2) in celiac patients with functional dyspepsia and non-celiac patients with functional dyspepsia

    Evaluating gastric emptying time by a 13C-Octanoic Acid Breath Test, pre and post-diet

    Six weeks

Secondary Outcomes (4)

  • Comparison of the effects of dietary recommendation for a diet low in Oligo-, Di- and Monosaccharides and Polyols (FODMAPs) or a balanced diet in celiac and non-celiac dyspeptic patients on gastric emptying time

    Six weeks

  • Evaluation of gastrointestinal symptoms (VAS)

    Six weeks

  • Evaluation of quality of life (SF-36)

    Six weeks

  • Evaluation of mental health (SCL-90)

    Six weeks

Study Arms (2)

Low Fodmap Gluten Free Diet

EXPERIMENTAL

Patients received dietary advice in the form of a table divided into two columns, one reporting the allowed food because low in FODMAPs and the other indicating the prohibited food due to its high continent of FODMAPs

Other: Dietary Intervention (Low Fodmap Gluten Free Diet)

Regular Gluten Free Diet

NO INTERVENTION

Patients received a table containing a list of allowed food based on a regular diet

Interventions

The intervention provides the administration of a Low Fodmap Diet to celiac or non celiac patients with functional gastrointestinal disorders

Low Fodmap Gluten Free Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age: ≥ 18 years old
  • gender: male or female
  • patients who have signed informed consent
  • patients diagnosed with a functional gastrointestinal disorder who meet Rome IV criteria (according to Rome Foundation's latest revision of 2016)

You may not qualify if:

  • patients who have not given informed consent
  • patients without a diagnosis of a functional gastrointestinal disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Leda Roncoroni

Milan, 20100, Italy

Location

Luca Elli

Milan, 20100, Italy

Location

Related Publications (6)

  • Bruno G, Lopetuso LR, Ianiro G, Laterza L, Gerardi V, Petito V, Poscia A, Gasbarrini A, Ojetti V, Scaldaferri F. 13C-octanoic acid breath test to study gastric emptying time. Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:59-64.

    PMID: 24443070BACKGROUND
  • Usai Satta P, Scarpa M, Oppia F, Loriga F. 13C-octanoic acid breath test in functional and organic disease: critical review of literature. Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5 Suppl 1):9-13.

    PMID: 16457124BACKGROUND
  • Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.

    PMID: 9817120BACKGROUND
  • Prunas A, Sarno I, Preti E, Madeddu F, Perugini M. Psychometric properties of the Italian version of the SCL-90-R: a study on a large community sample. Eur Psychiatry. 2012 Nov;27(8):591-7. doi: 10.1016/j.eurpsy.2010.12.006. Epub 2011 Feb 21.

    PMID: 21334861BACKGROUND
  • Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543. No abstract available.

    PMID: 22588748BACKGROUND
  • Massironi S, Branchi F, Fraquelli M, Baccarin A, Somalvico F, Ferretti F, Conte D, Elli L. Effects of a Gluten-Containing Meal on Gastric Emptying and Gallbladder Contraction. Nutrients. 2018 Jul 16;10(7):910. doi: 10.3390/nu10070910.

    PMID: 30012987BACKGROUND

MeSH Terms

Conditions

Gastrointestinal Diseases

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Digestive System Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Luca Elli, PhD, MD

    IRCCS Maggiore H

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2023

First Posted

July 28, 2025

Study Start

February 3, 2021

Primary Completion

November 30, 2023

Study Completion

April 30, 2024

Last Updated

July 28, 2025

Record last verified: 2022-12

Locations